![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Corporate information
Official name
Deerfield Capital Management Limited Liability Company
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 17 of 17| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Curon Medical Inc | N/A | ||||
|
|
Inhibitex Inc | N/A | ||||
|
|
Metabolex Inc | Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. | Series D | |||
|
|
MiddleBrook Pharmaceuticals Inc | A pharmaceutical company engages in the development and commercialization of anti-infective drug products. | N/A | |||
|
|
Novare Surgical Systems Inc | Series D | ||||
|
|
NxStage Medical Inc | Hemofiltration for kidney failure | N/A | |||
|
|
Optimer Pharmaceuticals Inc | Global biopharmaceutical company. | N/A | |||
|
|
Pacific Biosciences of California Inc | Provider of an integrated platform for genetic analysis. | Series F | |||
|
|
Pacific Biosciences of California Inc | Provider of an integrated platform for genetic analysis. | Series E | |||
|
|
Sunesis Pharmaceuticals Inc | Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he | N/A | |||
|
|
VIA Pharmaceuticals Inc | Drug development company targeting vascular inflammation. | N/A | |||
|
|
Align Technology Inc | N/A | ||||
|
Arena Pharmaceuticals Inc | Series A | ||||
|
CardioMEMS Inc | Medical device company that develops wireless medical pressure sensors. | Series F Initial investment | |||
|
|
CardioMEMS Inc | Medical device company that develops wireless medical pressure sensors. | Series E Initial investment | |||
|
Salix Pharmaceuticals Inc | US specialty pharmaceutical company | N/A | |||
|
|
Tengion Inc | A leading regenerative medicine company. | Series C Initial investment |